More recently, axonal loss has also been recognized as a feature of the disease, but the relationships between axonal loss, plaque formation and demyelination are unclear. In a postmortem study of ...

Chronic, irreversible motor disability in patients with multiple sclerosis (MS) correlates with axonal pathology rather than demyelination, according to new research. During the early stages of MS ...

Axon Enterprise (AXON) reached $610.32, with a -0.5% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.29%. On the other hand, the Dow ...

Axon Enterprise (AXON) closed the latest trading day at $665.08, indicating a -0.62% change from the previous session's end. The stock's performance was behind the S&P 500's daily loss of 0.27%.